June 23, 2024

Sleep Apnea Reduced in People Who Took Zepbound, Eli Lilly Reports

The company reported results of clinical trials involving Zepbound, an obesity drug in the same class as Novo Nordisk’s Wegovy.The company reported results of clinical trials involving Zepbound, an obesity drug in the same class as Novo Nordisk’s Wegovy.Read MoreTirzepatide, Sleep, Obesity, Clinical Trials, Eli Lilly and Company, Drugs (Pharmaceuticals), WeightNYT > Health

Leave a Reply

Your email address will not be published. Required fields are marked *